Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Biological Research for Nursing|February 4, 2014
Influence of mindfulness-based stress reduction (MBSR) on telomerase activity in women with breast cancer (BC)Cecile A Lengacher, Richard R Reich, Kevin E Kip, et al.
Journal of Integrative and Complementary Medicine|September 18, 2024
Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled TrialCecile A Lengacher, Richard R Reich, Carmen S Rodriguez, et al.
Psycho-Oncology|July 23, 2025
Cost-Utility Analysis of a Group Mindfulness Program Compared to an Education Support Program for Breast Cancer Survivors With Cognitive Impairment: Evidence From a Randomized Controlled TrialHongdao Meng, Cecile A Lengacher, Rio Tate, et al.
Plos Neglected Tropical Diseases|September 15, 2016
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialMonique Wasunna, Simon Njenga, Manica Balasegaram, et al.
Biological Research for Nursing|October 16, 2024
The Moderating Role of Genetics on the Effectiveness of the Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) Program on Cognitive ImpairmentJong Y Park, Cecile A Lengacher, Carmen S Rodriguez, et al.
Open Forum Infectious Diseases|July 12, 2021
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJ Ryan Bariola, Erin K McCreary, Richard J Wadas, et al.
Journal of Integrative and Complementary Medicine|December 23, 2024
A Randomized Clinical Trial of Mindfulness-Based Stress Reduction Program Among Breast Cancer Survivors Post-Treatment: Evaluating Mediators of Cognitive ImprovementCecile A Lengacher, Gizem Hueluer, Julia R Wang, et al.
Sleep|February 23, 2019
Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changesOmonigho M Bubu, Elizabeth Pirraglia, Andreia G Andrade, et al.
JAMA Network Open|April 12, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, J Ryan Bariola, Richard J Wadas, et al.
Trials|May 26, 2021
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomizationDavid T Huang, Erin K McCreary, J Ryan Bariola, et al.
Pageof 22